These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 23640177)
21. First description of enhanced expression of glia maturation factor-beta in experimental toxoplasmic encephalitis. Dincel GC J Int Med Res; 2017 Dec; 45(6):1670-1679. PubMed ID: 28774213 [TBL] [Abstract][Full Text] [Related]
22. A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines. Zaheer A; Zaheer S; Sahu SK; Knight S; Khosravi H; Mathur SN; Lim R J Neurochem; 2007 Apr; 101(2):364-76. PubMed ID: 17250654 [TBL] [Abstract][Full Text] [Related]
23. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease. García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555 [TBL] [Abstract][Full Text] [Related]
24. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017 [TBL] [Abstract][Full Text] [Related]
25. Glia Maturation Factor (GMF) Regulates Microglial Expression Phenotypes and the Associated Neurological Deficits in a Mouse Model of Traumatic Brain Injury. Ahmed ME; Selvakumar GP; Kempuraj D; Raikwar SP; Thangavel R; Bazley K; Wu K; Khan O; Khan A; Zaheer S; Iyer S; Burton C; James D; Zaheer A Mol Neurobiol; 2020 Nov; 57(11):4438-4450. PubMed ID: 32737763 [TBL] [Abstract][Full Text] [Related]
26. Synergy in Disruption of Mitochondrial Dynamics by Aβ (1-42) and Glia Maturation Factor (GMF) in SH-SY5Y Cells Is Mediated Through Alterations in Fission and Fusion Proteins. Ahmed ME; Selvakumar GP; Kempuraj D; Thangavel R; Mentor S; Dubova I; Raikwar SP; Zaheer S; Iyer S; Zaheer A Mol Neurobiol; 2019 Oct; 56(10):6964-6975. PubMed ID: 30949973 [TBL] [Abstract][Full Text] [Related]
27. Memory performance is related to amyloid and tau pathology in the hippocampus. Reitz C; Honig L; Vonsattel JP; Tang MX; Mayeux R J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):715-21. PubMed ID: 19258354 [TBL] [Abstract][Full Text] [Related]
28. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946 [TBL] [Abstract][Full Text] [Related]
29. Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease. Thangavel R; Sahu SK; Van Hoesen GW; Zaheer A Neuroscience; 2009 May; 160(2):427-33. PubMed ID: 19250962 [TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517 [TBL] [Abstract][Full Text] [Related]
31. Phosphatidylinositol-4,5-bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles. Nishikawa T; Takahashi T; Nakamori M; Yamazaki Y; Kurashige T; Nagano Y; Nishida Y; Izumi Y; Matsumoto M Neuropathol Appl Neurobiol; 2014 Jun; 40(4):489-501. PubMed ID: 23631697 [TBL] [Abstract][Full Text] [Related]
32. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Streit WJ; Braak H; Xue QS; Bechmann I Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731 [TBL] [Abstract][Full Text] [Related]
33. Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains. Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K Neuropathol Appl Neurobiol; 2013 Feb; 39(2):109-20. PubMed ID: 22582881 [TBL] [Abstract][Full Text] [Related]
34. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains. Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244 [TBL] [Abstract][Full Text] [Related]
35. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains. Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795 [TBL] [Abstract][Full Text] [Related]
36. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease. Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311 [TBL] [Abstract][Full Text] [Related]
37. Transfection of C6 glioma cells with glia maturation factor upregulates brain-derived neurotrophic factor and nerve growth factor: trophic effects and protection against ethanol toxicity in cerebellar granule cells. Pantazis NJ; Zaheer A; Dai D; Zaheer S; Green SH; Lim R Brain Res; 2000 May; 865(1):59-76. PubMed ID: 10814733 [TBL] [Abstract][Full Text] [Related]
38. Glia maturation factor overexpression in neuroblastoma cells activates glycogen synthase kinase-3beta and caspase-3. Zaheer A; Knight S; Zaheer A; Ahrens M; Sahu SK; Yang B Brain Res; 2008 Jan; 1190():206-14. PubMed ID: 18054898 [TBL] [Abstract][Full Text] [Related]
39. A plasticity-based theory of the pathogenesis of Alzheimer's disease. Mesulam MM Ann N Y Acad Sci; 2000; 924():42-52. PubMed ID: 11193801 [TBL] [Abstract][Full Text] [Related]
40. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]